DLD laboratory
Excellence in In-Vitro Diagnostics

Reliable Diagnostics
Specialized Tests

DLD is the interface between research and routine laboratories. We distribute high-quality "niche tests" for autoimmune diseases, cardiovascular health, oncology, and renal function disorders.

Explore Products Contact Sales
Established 1994

Bridge between Research & Routine Laboratories

DLD Gesellschaft für Diagnostika und medizinische Geräte mbH develops, distributes, and provides scientific service for high-quality innovative tests for in-vitro diagnostics.

Our methodology is mainly based on immunoassay techniques such as Radioimmunoassays (RIA) and Enzyme Immunoassays (ELISA). We stand for innovative products and research and development at a high level in cooperation with leading international study groups.

Specialized Niche Tests

High-quality assays for specific diagnostic questions.

Expert Scientific Support

Direct support from our scientific team.

Global Distribution Network

Worldwide availability through our partners.

Read Company Profile
Our Portfolio

Product Range

13 product groups with clearly labeled IVD, RUO, and veterinary assays for specialized diagnostic needs.

Note: We clearly distinguish between products for in-vitro diagnostics (IVD) and products intended exclusively for research use (RUO). Please note the corresponding labeling.

Biogene Amine Biogenic amines

13

Breites Panel für Histamin, Serotonin, Katecholamine und Metanephrine. Broad panel for histamine, serotonin, catecholamines and metanephrines.

Diabetes mellitus Typ 1 Type 1 diabetes mellitus

10

Screening- und Einzelmarker-Assays für autoimmune Diabetesdiagnostik. Screening and single-marker assays for autoimmune diabetes diagnostics.

View full product catalog

Latest News & Studies

Updates from the world of diagnostics.

März 2024 March 2024

Erweitertes Vorsorgeangebot zur Früherkennung von Mesotheliomen (EVA-Mesothel) Extended screening program for the early detection of occupational mesothelioma (EVA-Mesothel)

"Die Zahlen beruflich bedingter Tumoren des Brustfells, Bauchfells u.a. seröser Häute (sog. Mesotheliome) befinden sich trotz Asbestverbots im Jahr 1993 weiterhin auf einem hohen Niveau. Im Jahr 2022 wurden von den Unfa… "The number of occupational mesotheliomas is still at a high level despite the ban on asbestos in 1993 in Germany. In 2021 the German Social Accident Insurance (DGUV) reported about 700 new cases of recognized occupatio…
Read Full Article

März 2024 March 2024

CAR-T-Zell-Therapie macht Hoffnung bei Autoimmunkrankheiten CAR T-cell therapy offers hope for autoimmune diseases

Erste Erfolge mit CAR-T-Zell-Therapien bei Myasthenie und andere Autoimmunerkrankungen machen große Hoffnungen. Chimäre (Auto-) Antigen Rezeptor T-Zellen (CAR-T-Zellen) sind Immunzellen, genauer T-Lymphozyten, die dem P… Initial successes with CAR-T-cell therapies for myasthenia and other autoimmune diseases give great hope. Chimeric (auto) antigen receptor T-cells (CAR-T-cells) are immune cells, more precisely T-lymphocytes, which are…
Read Full Article

April 2023 April 2023

Canine ACHRAB RIA: Ein neuer RIA zur Diagnose von Myasthenia gravis bei Hunden Canine ACHRAB RIA: A new RIA for the diagnosis of myasthenia gravis in dogs

"Klinische Validierung eines neuen Radioimmunoassays für die Diagnose von Myasthenia gravis bei Hunden Einleitung: Die erworbene Myasthenia gravis des Hundes ist eine Autoimmunerkrankung der neuromuskulären Endplatte. P… "Clinical validation of a new radioimmunoassay for the diagnosis of myasthenia gravis in dogs. Introduction: Acquired canine myasthenia gravis is an autoimmune disease of the neuromuscular endplate. Pathophysiologically…
Read Full Article
View all news
Management

Leadership & Tradition

Headquartered in Hamburg and founded in 1994, DLD is led by Dr. Karen Münzner and Janet Bradbury. With over three decades of experience, we stand for high-class research and reliable quality "Made in Germany".